Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-3811016
  • Global Allergy Diagnostics And Therapeutics Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: February 2017 | Report Code: HPH-3811016

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Allergy diagnostics and therapeutics involves novel diagnostics and therapeutic products for treating allergies and diseases leading to allergies. In 2016, the total global revenue of allergy diagnostics and therapeutics market was $5810million. The global revenues of allergy diagnostics and therapeutic market by 2023 is anticipated to reach $14,279million, growing at CAGR 21.5% during period 2016-2023. Increasing healthcare expenditure and rising prevalence rate of allergy diseases are the main drivers of the market for the forecasted period. According to American Academy of Allergy Asthma and Immunology (AAAAI) in 2015 over 8million children and 15million adults suffered from respiratory allergies worldwide. AAAAI epidemiological study confirms, allergies like respiratory, food and eczema are the most common chronic non-communicable diseases amongst people in the world. An average 10% of the total global population suffer from food allergy. An average 20% of the children aged between zero and ten suffer from food allergy in US in 2015. According to American College of Allergy, Asthma & Immunology (ACAAI), in 2015 over 10% of total children in US is suffering from some form of skin allergies. International Study of Asthma and Allergies in Childhood (ISAAC) stated pollen allergy prevalence for children age between thirteen and sixteen years were 22.1% globally. Worldwide prevalence of rhinitis in 2015 was between 10% and 30% of the population. An average 20 million adult population in US is diagnosed with hay fever every year according to AAAAI. According to European Journal of Allergy and Clinical Immunology (EJACI) the most the common form of allergy affecting European population is food allergy and hay fever. An average 20% of the total population in Europe are affected every year with food allergy. Hay fever prevalence has increased by 7% since 2015. Hay fever is more prevalent in Western Europe. Other allergies include pollen allergy, skin allergy, asthma and gluten allergy. Prevalence of pollen allergies is higher among Eastern European population. Allergic rhinitis and asthma are the most common forms of allergy in Asia Pacific. Prevalence of rhinitis is higher in countries like Thailand, Indonesia, Singapore, Korea and New Zealand. Whereas, prevalence of asthma in higher in China, India, Japan, Australia, Malaysia, and Bangladesh. According to According to Asia Pacific Association of Allergy, Asthma and Clinical Immunology, the prevalence of rate of asthma in China and India has increased by over 11% in 2015. Every year, an average 2% of the total population in China and India is diagnosed with asthma. Increasing prevalence of chronic allergies is a grave matter every government looking forward to address. Suffice to say increasing prevalence would supplement allergy diagnostic and therapeutic market growth for the forecast period 2016-2023.

Global allergy diagnostics and therapeutics market is segmented as types of allergies, products and end users. In terms of allergy type the market is bifurcated into food, inhaled and other allergies. With increasing prevalence rate, food allergy dominates the allergy type segment. Products segment is classified as assay kits, consumables and instruments. Consumables dominate the market in terms of revenue, due to increasing demand for cure of allergies via drugs. End user segment is divided into academic research centres, diagnostic labs, hospitals, and others. With increasing demand for diagnostics test in public institutions hospital end user segment is anticipated to growth with highest numbers.

The market drivers discussed in the report includes, rising pollution levels, increasing healthcare expenditure, increasing prevalence rate of allergic diseases and expanding IVD market.  High initial capital requirement, lack of awareness about allergic diseases, stringent medical laws & regulations, and market competition are some of the factors impacting the market in medium term deliberated in the report.

Geographically, allergy diagnostics and therapeutic market is classified into North America, Europe, Asia Pacific and Rest of the World (ROW). North America dominates the market in terms of revenue followed by Europe. Presence of large pool of drugs and diagnostic companies, increasing prevalence of allergic diseases, growing awareness about treatment, and sound regulatory environment are the factors driving the market in North America and Europe. Asia Pacific is the fastest growing market for the forecast period 2016-2023. India, China, Japan, and Australia are the leading the market growth in Asia Pacific. Increasing healthcare expenditure, increasing prevalence rate of allergic disorders, demand for quality treatment and changing regulatory reforms are the key factors driving allergic diagnostics and therapeutics market in Asia Pacific for the forecasted period.

Some of the pioneer in allergic diagnostics and therapeutics market are Danaher Corporation., HoB Biotech Group., Hycor Biomedical Inc., Omgea Diagnostics Ltd., Thermo Fischer Scientific Pvt Ltd., Biomerieux Inc., Siemens Healthcare Ltd., and Hitahchi Diagnostics Inc. The market report provides annual revenues of each company’s along with SCOT analysis and popular products that are being manufactured. Collaboration, partnerships, memorandum of understanding, merger & acquisition and joint ventures are some of the strategies used by companies. On 13th February 2017, Dublin based Allergan Inc., acquired California (US) based Zeltiq Aesthetics for $2.475bilion. The acquisition provides Allergan Inc., an opportunity to expand its product portfolio in dermatology and plastic surgery. Similarly, Portugal based BIAL has decided to sell its immunotherapy business unit to Germany based Roxall Inc. The deal provides Roxall Inc., an array of products manufactured by BIAL and opportunities in markets of Italy, Spain and Portugal.

1.      INTRODUCTION

1.1.EXECUTIVE SUMMARY

1.2.MARKET SCOPE

2.      MARKET OVERVIEW

2.1.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: EVOLUTION & TRANSITION

2.2.INDUSTRY STRUCTURE

2.3.REGULATORY FRAMEWORK

2.4.TOTAL MARKET ANALYSIS

2.4.1.      TOP FINDINGS

2.4.2.      TOP OPPORTUNITY MARKETS

2.4.3.      TOP COMPANIES

2.4.4.      TOP COMPETITIVE STRATEGIES

2.5.ESTIMATION ANALYSIS

2.6.STRATEGIC ANALYSIS

2.6.1.      INVESTMENT VS. ADOPTION MODEL

2.6.2.      360 DEGREE INDUSTRY ANALYSIS

2.6.3.      PORTERS 5 FORCE MODEL

2.6.4.      SEE-SAW ANALYSIS

2.6.5.      PRICING ANALYSIS

2.6.6.      CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.6.7.      ROI ANALYSIS

2.6.8.      GAP ANALYSIS

2.7.COMPETITIVE ANALYSIS

2.7.1.      KEY STRATEGIES AND ANALYSIS

2.7.2.      MARKET SHARE

2.7.3.      TOP COMPANY ANALYSIS

2.8.STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.8.1.      INVESTMENT OPPORTUNITIES BY REGIONS

2.8.2.      OPPORTUNITIES IN EMERGING APPLICATIONS

2.8.3.      INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.      MARKET DETERMINANTS

3.1.MARKET DRIVERS & MARKET IMPACT

3.1.1.                  RISING POLLUTION LEVELS

3.1.2.                  INCREASING HEALTHCARE EXPENDITURE

3.1.3.                  INCREASING PREVALENCE RATE OF ALLERGIC DISEASES

3.1.4.                  EXPANDING IVD MARKET

3.2.MARKET RESTRAINTS& MARKET IMPACT

3.2.1.                  HIGH INITIAL CAPITAL REQUIREMENT

3.2.2.                  LACK OF AWARENESS ABOUT ALLERGIC DISEASES

3.2.3.                  STRINGENT MEDICAL LAWS & REGULATIONS

3.3.MARKET OPPORTUNITIES

3.3.1.      EMERGING ECONOMIES LIKE INDIA AND CHINA

3.3.2.      ADVENT OF ALLERGEN CHIPS

3.3.3.      LABORATORY AUTOMATION

3.4.MARKET CHALLENGES

3.4.1.      MARKET COMPETITION

3.4.2.      DEMAND FOR SENSITIVE AND ACCURATE DIAGNOSTIC TOOLS

4.      MARKET SEGMENTATION

4.1.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY TYPE

4.1.1.      MARKET DEFINITION AND SCOPE

4.1.2.      DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.1.3.      COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.1.4.       OPPORTUNITY MATRIX

4.1.5.       MARKET SEGMENTATION

4.1.5.1.FOOD

4.1.5.1.1.      APPLICATIONS

4.1.5.1.2.      ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.1.3.      MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.1.4.      TOP PLAYERS & KEY PRODUCTS

4.1.5.1.5.      KEY CONCLUSIONS

4.1.5.2.INHALED

4.1.5.2.1.      APPLICATIONS

4.1.5.2.2.      ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.2.3.      MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.2.4.      TOP PLAYERS & KEY PRODUCTS

4.1.5.2.5.      KEY CONCLUSIONS

4.1.5.3.OTHER TYPES

4.1.5.3.1.      APPLICATIONS

4.1.5.3.2.      ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.3.3.      MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.3.4.      TOP PLAYERS & KEY PRODUCTS

4.1.5.3.5.      KEY CONCLUSIONS

4.2.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY  PRODUCTS

4.2.1.      MARKET DEFINITION AND SCOPE

4.2.2.      DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.2.3.      COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.2.4.       OPPORTUNITY MATRIX

4.2.5.       MARKET SEGMENTATION

4.2.5.1.ASSAY KITS

4.2.5.1.1.      APPLICATIONS

4.2.5.1.2.      ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.1.3.      MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.1.4.      TOP PLAYERS & KEY PRODUCTS

4.2.5.1.5.      KEY CONCLUSIONS

4.2.5.2.CONSUMABLES

4.2.5.2.1.      APPLICATIONS

4.2.5.2.2.      ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.2.3.      MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.2.4.      TOP PLAYERS & KEY PRODUCTS

4.2.5.2.5.      KEY CONCLUSIONS

4.2.5.3.INSTRUMENTS

4.2.5.3.1.      APPLICATIONS

4.2.5.3.2.      ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.3.3.      MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.3.4.      TOP PLAYERS & KEY PRODUCTS

4.2.5.3.5.      KEY CONCLUSIONS

4.3.GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY  END USERS

4.3.1.      MARKET DEFINITION AND SCOPE

4.3.2.      DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.3.      COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.3.4.       OPPORTUNITY MATRIX

4.3.5.       MARKET SEGMENTATION

4.3.5.1.ACADEMIC RESEARCH CENTERS

4.3.5.1.1.      APPLICATIONS

4.3.5.1.2.      ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.1.3.      MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.1.4.      TOP PLAYERS & KEY PRODUCTS

4.3.5.1.5.      KEY CONCLUSIONS

 

4.3.5.2.DIAGNOSTIC LABORATORIES

4.3.5.2.1.      APPLICATIONS

4.3.5.2.2.      ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.2.3.      MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.2.4.      TOP PLAYERS & KEY PRODUCTS

4.3.5.2.5.      KEY CONCLUSIONS

 

4.3.5.3.HOSPITALS

4.3.5.3.1.      APPLICATIONS

4.3.5.3.2.      ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.3.3.      MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.3.4.      TOP PLAYERS & KEY PRODUCTS

4.3.5.3.5.      KEY CONCLUSIONS

 

4.3.5.4.OTHER END USERS

4.3.5.4.1.      APPLICATIONS

4.3.5.4.2.      ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.4.3.      MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.4.4.      TOP PLAYERS & KEY PRODUCTS

4.3.5.4.5.      KEY CONCLUSIONS

 

5.      COMPETITIVE LANDSCAPE

5.1.KEY STRATEGIES

5.1.1.      LIST OF M&A

5.1.2.      LIST OF JV

5.1.3.      LIST OF PRODUCT LAUNCHES

5.1.4.      LIST OF PARTNERSHIP

5.2.TOP 10 COMPANY ANALYSIS – DASHBOARD

6.      GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY REGION

6.1.DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.2.COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.3.OPPORTUNITY MATRIX

6.4.GEOGRAPHIC SEGMENTATION

6.4.1.      NORTH AMERICA

6.4.1.1.INDUSTRY APPLICATION ANALYSIS

6.4.1.2.TOP COUNTRY ANALYSIS

6.4.1.2.1.      U.S.

6.4.1.2.1.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.1.2.TOP PLAYERS & KEY PRODUCTS

6.4.1.2.1.3.KEY CONCLUSIONS

6.4.1.2.2.      CANADA

6.4.1.2.2.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.2.2.TOP PLAYERS & KEY PRODUCTS

6.4.1.2.2.3.KEY CONCLUSIONS

6.4.2.      EUROPE

6.4.2.1.INDUSTRY APPLICATION ANALYSIS

6.4.2.2.TOP COUNTRY ANALYSIS

6.4.2.2.1.      UK

6.4.2.2.1.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.1.2.TOP PLAYERS & KEY PRODUCTS

6.4.2.2.1.3.KEY CONCLUSIONS

6.4.2.2.2.      FRANCE

6.4.2.2.2.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.2.2.TOP PLAYERS & KEY PRODUCTS

6.4.2.2.2.3.KEY CONCLUSIONS

6.4.2.2.3.      GERMANY

6.4.2.2.3.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.3.2.TOP PLAYERS & KEY PRODUCTS

6.4.2.2.3.3.KEY CONCLUSIONS

6.4.2.2.4.      SPAIN

6.4.2.2.4.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.4.2.TOP PLAYERS & KEY PRODUCTS

6.4.2.2.4.3.KEY CONCLUSIONS

6.4.2.2.5.      ITALY

6.4.2.2.5.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.5.2.TOP PLAYERS & KEY PRODUCTS

6.4.2.2.5.3.KEY CONCLUSIONS

6.4.2.2.6.      REST OF EUROPE

6.4.2.2.6.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.6.2.TOP PLAYERS & KEY PRODUCTS

6.4.2.2.6.3.KEY CONCLUSIONS

6.4.3.      ASIA PACIFIC

6.4.3.1.INDUSTRY APPLICATION ANALYSIS

6.4.3.2.TOP COUNTRY ANALYSIS

6.4.3.2.1.      CHINA

6.4.3.2.1.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.1.2.TOP PLAYERS & KEY PRODUCTS

6.4.3.2.1.3.KEY CONCLUSIONS

6.4.3.2.2.      INDIA

6.4.3.2.2.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.2.2.TOP PLAYERS & KEY PRODUCTS

6.4.3.2.2.3.KEY CONCLUSIONS

6.4.3.2.3.      JAPAN

6.4.3.2.3.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.3.2.TOP PLAYERS & KEY PRODUCTS

6.4.3.2.3.3.KEY CONCLUSIONS

6.4.3.2.4.      SOUTH KOREA

6.4.3.2.4.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.4.2.TOP PLAYERS & KEY PRODUCTS

6.4.3.2.4.3.KEY CONCLUSIONS

6.4.3.2.5.      AUSTRALIA

6.4.3.2.5.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.5.2.TOP PLAYERS & KEY PRODUCTS

6.4.3.2.5.3.KEY CONCLUSIONS

6.4.3.2.6.      REST OF ASIA PACIFIC

6.4.3.2.6.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.6.2.TOP PLAYERS & KEY PRODUCTS

6.4.3.2.6.3.KEY CONCLUSIONS

6.4.4.      ROW

6.4.4.1.INDUSTRY APPLICATION ANALYSIS

6.4.4.2.TOP COUNTRY ANALYSIS

6.4.4.2.1.      LATIN AMERICA

6.4.4.2.1.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.1.2.TOP PLAYERS & KEY PRODUCTS

6.4.4.2.1.3.KEY CONCLUSIONS

6.4.4.2.2.      MIDDLE EAST & AFRICA

6.4.4.2.2.1.MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.2.2.TOP PLAYERS & KEY PRODUCTS

6.4.4.2.2.3.KEY CONCLUSIONS

7.      COMPANY PROFILES

7.1.ALCON LABS

7.1.1.        OVERVIEW

7.1.2.      PRODUCT PORTFOLIO

7.1.3.      KEY INNOVATION SECTOR

7.1.4.      STRATEGIC INITIATIVES

7.1.5.      SCOT ANALYSIS

7.2.ALLERCHECK INC 

7.2.1.      OVERVIEW

7.2.2.      PRODUCT PORTFOLIO

7.2.3.      KEY INNOVATION SECTOR

7.2.4.      STRATEGIC INITIATIVES

7.2.5.      SCOT ANALYSIS

7.3.BIOMERIEUX

7.3.1.      OVERVIEW

7.3.2.      PRODUCT PORTFOLIO

7.3.3.      KEY INNOVATION SECTOR

7.3.4.      STRATEGIC INITIATIVES

7.3.5.      SCOT ANALYSIS

7.4.DANAHER CORPORATION

7.4.1.      OVERVIEW

7.4.2.      PRODUCT PORTFOLIO

7.4.3.      KEY INNOVATION SECTOR

7.4.4.      STRATEGIC INITIATIVES

7.4.5.      SCOT ANALYSIS

7.5.HITACHI CHEMICAL DIAGNOSTICS

7.5.1.      OVERVIEW

7.5.2.      PRODUCT PORTFOLIO

7.5.3.      KEY INNOVATION SECTOR

7.5.4.      STRATEGIC INITIATIVES

7.5.5.      SCOT ANALYSIS

7.6.HOB BIOTECH GROUP 

7.6.1.      OVERVIEW

7.6.2.      PRODUCT PORTFOLIO

7.6.3.      KEY INNOVATION SECTOR

7.6.4.      STRATEGIC INITIATIVES

7.6.5.      SCOT ANALYSIS

7.7.HYCOR BIOMEDICAL 

7.7.1.      OVERVIEW

7.7.2.      PRODUCT PORTFOLIO

7.7.3.      KEY INNOVATION SECTOR

7.7.4.      STRATEGIC INITIATIVES

7.7.5.      SCOT ANALYSIS

7.8.LINCOLN DIAGNOSTICS 

7.8.1.      OVERVIEW

7.8.2.      PRODUCT PORTFOLIO

7.8.3.      KEY INNOVATION SECTOR

7.8.4.      STRATEGIC INITIATIVES

7.8.5.      SCOT ANALYSIS

7.9.NIDEC CORP

7.9.1.      OVERVIEW

7.9.2.      PRODUCT PORTFOLIO

7.9.3.      KEY INNOVATION SECTOR

7.9.4.      STRATEGIC INITIATIVES

7.9.5.      SCOT ANALYSIS

7.10.        OMEGA DIAGNOSTICS

7.10.1.  OVERVIEW

7.10.2.  PRODUCT PORTFOLIO

7.10.3.  KEY INNOVATION SECTOR

7.10.4.  STRATEGIC INITIATIVES

7.10.5.  SCOT ANALYSIS

7.11.        SIEMENS HEALTHCARE

7.11.1.  OVERVIEW

7.11.2.  PRODUCT PORTFOLIO

7.11.3.  KEY INNOVATION SECTOR

7.11.4.  STRATEGIC INITIATIVES

7.11.5.  SCOT ANALYSIS

7.12.        STALLERGENES

7.12.1.  OVERVIEW

7.12.2.  PRODUCT PORTFOLIO

7.12.3.  KEY INNOVATION SECTOR

7.12.4.  STRATEGIC INITIATIVES

7.12.5.  SCOT ANALYSIS

7.13.        THERMO FISCHER SCIENTIFIC PVT LTD

7.13.1.  OVERVIEW

7.13.2.  PRODUCT PORTFOLIO

7.13.3.  KEY INNOVATION SECTOR

7.13.4.  STRATEGIC INITIATIVES

7.13.5.  SCOT ANALYSIS

 

 

LIST OF TABLES

 

1.           GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY PACKAGE TYPE2014-2023 ($ MILLION)

2.           GLOBAL PRIMARY ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

3.           GLOBAL SECONDARY ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

4.           GLOBAL LABELING & SERIALIZATION EQUIPMENT MARKET BY PRODUCT 2014-2023 ($ MILLION)

5.           GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY PRODUCT TYPE 2014-2023 ($ MILLION)

6.           GLOBAL LIQUIDS ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

7.           GLOBAL SOLIDS ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

8.           GLOBAL SEMI-SOLIDS ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

9.           GLOBAL OTHER PRODUCTS ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

10.       NORTH AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

11.       EUROPE ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

12.       ASIA PACIFIC ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

13.       REST OF THE WORLD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

1.      GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY PRIMARY PHARMACEUTICAL PACKAGING EQUIPMENT 2014-2023 ($ MILLION)

2.      GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY ASEPTIC FILLING AND SEALING EQUIPMENT 2014-2023 ($ MILLION)

3.      GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY BOTTLES FILLING AND CAPPING EQUIPMENT 2014-2023 ($ MILLION)

4.      GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY BLISTER PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

5.      GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY SOFT-TUBE FILLING AND SEALING MACHINES  2014-2023 ($ MILLION)

6.      GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY SACHET PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

7.      GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY STRIP PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

8.      GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY COUNTING EQUIPMENT 2014-2023 ($ MILLION)

9.      GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY OTHERS 2014-2023 ($ MILLION)

10.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY SECONDARY PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

11.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY CARTONING EQUIPMENT2014-2023 ($ MILLION)

12.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY CASE PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

13.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY WRAPPING EQUIPMENT  2014-2023 ($ MILLION)

14.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY TRAY PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

15.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY PALLETIZING AND DEPALLETIZING EQUIPMENT2014-2023 ($ MILLION)

16.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY LABELING & SERIALIZATION EQUIPMENT 2014-2023 ($ MILLION)

17.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY LIQUIDS PHARMACEUTICAL PACKAGING EQUIPMENT 2014-2023 ($ MILLION)

18.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY ASEPTIC LIQUIDS PACKAGING EQUIPMENT2014-2023 ($ MILLION)

19.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY SYRUP PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

20.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY  EYE/EAR DROP PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

21.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY AEROSOL PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

22.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY OTHER LIQUIDS PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

23.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY SOLIDS PHARMACEUTICAL PACKAGING EQUIPMENT 2014-2023 ($ MILLION)

24.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY TABLET PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

25.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY CAPSULE PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

26.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY  POWDER PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

27.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY GRANULE PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

28.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY OTHER SOLIDS PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

29.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY SEMI-SOLIDS PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

30.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY  OINTMENT PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

31.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY CREAM PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

32.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY SUPPOSITORY PACKAGING EQUIPMENT2014-2023 ($ MILLION)

33.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY OTHER SEMI-SOLIDS PHARMACEUTICAL PACKAGING EQUIPMENT 2014-2023 ($ MILLION)

34.  GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY  OTHER PRODUCTS PHARMACEUTICAL PACKAGING EQUIPMENT2014-2023 ($ MILLION)

35.  UNITED STATES (U.S.) ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

36.  CANADA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

37.  UNITED KINGDOM (UK) ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

38.  FRANCE ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

39.  GERMANY ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

40.  SPAIN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

41.  ITALY ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

42.  ROE ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

43.  INDIA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

44.  CHINA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

45.  JAPAN ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

46.  KOREA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

47.  AUSTRALIA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

48.  ROW APAC ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

49.  LATIN AMERICA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

        50. MENA ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion